Warisawa, Takayuki
Cook, Christopher M.
Kawase, Yoshiaki
Howard, James P.
Ahmad, Yousif
Seligman, Henry
Rajkumar, Christopher
Toya, Takumi
Doi, Shunichi
Nakajima, Akihiro
Tanigaki, Toru
Omori, Hiroyuki
Nakayama, Masafumi
Vera-Urquiza, Rafael
Yuasa, Sonoka
Sato, Takao
Kikuta, Yuetsu
Nishina, Hidetaka
Al-Lamee, Rasha
Sen, Sayan
Lerman, Amir
Akashi, Yoshihiro J.
Escaned, Javier
Matsuo, Hitoshi
Davies, Justin E.
Article History
Received: 4 February 2023
Accepted: 27 March 2023
First Online: 5 April 2023
Declarations
:
: TW has received consulting fees from Abbott Medical Japan and Philips Japan. CMC has received speaker’s honoraria from Philips Volcano and Boston Scientific. HS has received a research grant from Amgen. JPH is supported by the Wellcome Trust (212183/Z/18/Z). YK reports speaker fees from Abbott Vascular and Philips. SS is supported by the Academy of Medical Sciences and Imperial Biomedical Research Centre. SS (G1000357) is supported by the Medical Research Council; and has served on the Speakers Bureau and participated in educational events for Pfizer, Phillips, Daichi-Sankyo, and AstraZeneca; and has received speaker fees from Volcano, Pfizer, and Medtronic. RAL has received a speaker honorarium from Philips Volcano. HM receive consultant fee from Zeon Medical, and speaker fee from Abbott Vascular Japan, Philips Japan, Boston Scientific Japan. JED holds patents pertaining to the iFR technology. JED is a consultant for Philips Volcano and has received research grants from Philips Volcano. All other authors declare no conflicts of interest.